Clinical Trials
8
Active:0
Completed:5
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (50.0%)Phase 2
3 (37.5%)Phase 1
1 (12.5%)Combined Pharmacotherapies for Alcoholism
Phase 3
Completed
- Conditions
- Alcoholism
- Interventions
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bankole Johnson
- Target Recruit Count
- 300
- Registration Number
- NCT00768508
- Locations
- 🇺🇸
UVA CARE, Charlottesville, Virginia, United States
🇺🇸UVA CARE Richmond, Richmond, Virginia, United States
Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- Bankole Johnson
- Target Recruit Count
- 4
- Registration Number
- NCT00769158
- Locations
- 🇺🇸
UVA CARE, Charlottesville, Virginia, United States
🇺🇸UVA CARE Richmond, Richmond, Virginia, United States
Novel Pharmacotherapy for Dual Dependence
Phase 3
- Conditions
- Alcohol DependenceCocaine Dependence
- Interventions
- Drug: Placebo + Cognitive Behavioral Therapy
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bankole Johnson
- Target Recruit Count
- 180
- Registration Number
- NCT00448825
- Locations
- 🇺🇸
University of Virginia Center for Addiction Research and Education, Richmond, Virginia, United States
Pharmacological Treatment for Alcoholism
Phase 3
Completed
- Conditions
- Alcohol Dependence
- Interventions
- Drug: Placebo + Cognitive Behavioral Therapy
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- Bankole Johnson
- Target Recruit Count
- 283
- Registration Number
- NCT00382642
- Locations
- 🇺🇸
UVA Center for Addiction Research and Education, Charlottesville, Virginia, United States
Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1
Phase 3
- Conditions
- Cocaine-Related Disorders
- Interventions
- Drug: Placebo + Cognitive Behavioral Therapy
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Bankole Johnson
- Target Recruit Count
- 180
- Registration Number
- NCT00249691
- Locations
- 🇺🇸
UVA CARE, Charlottesville, Virginia, United States
🇺🇸UVA CARE Richmond, Richmond, Virginia, United States
- Prev
- 1
- 2
- Next
News
No news found